These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29653895)

  • 1. An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model.
    Price DJ; Drewry DH; Schaller LT; Thompson BD; Reid PR; Maloney PR; Liang X; Banker P; Buckholz RG; Selley PK; McDonald OB; Smith JL; Shearer TW; Cox RF; Williams SP; Reid RA; Tacconi S; Faggioni F; Piubelli C; Sartori I; Tessari M; Wang TY
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1958-1963. PubMed ID: 29653895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
    Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
    Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
    Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
    J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
    O'Byrne SN; Scott JW; Pilotte JR; Santiago ADS; Langendorf CG; Oakhill JS; Eduful BJ; Couñago RM; Wells CI; Zuercher WJ; Willson TM; Drewry DH
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31941153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and structural analyses of potent inhibitors of the human Ca
    Profeta GS; Dos Reis CV; Santiago ADS; Godoi PHC; Fala AM; Wells CI; Sartori R; Salmazo APT; Ramos PZ; Massirer KB; Elkins JM; Drewry DH; Gileadi O; Couñago RM
    Sci Rep; 2019 Nov; 9(1):16452. PubMed ID: 31712618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calcium/calmodulin-dependent protein kinase kinase 2.
    Chang F; Zhang LH; Xu WP; Jing P; Zhan PY
    Mol Med Rep; 2014 May; 9(5):1917-22. PubMed ID: 24603903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
    Asquith CRM; Godoi PH; Couñago RM; Laitinen T; Scott JW; Langendorf CG; Oakhill JS; Drewry DH; Zuercher WJ; Koutentis PA; Willson TM; Kalogirou AS
    Molecules; 2018 May; 23(5):. PubMed ID: 29783765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor.
    Bowers S; Truong AP; Neitz RJ; Neitzel M; Probst GD; Hom RK; Peterson B; Galemmo RA; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Brigham EF; Quinn KP; Sauer JM; Powell K; Ruslim L; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1838-43. PubMed ID: 21316234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKK2 Suppresses Muscle Regeneration through the Inhibition of Myoblast Proliferation and Differentiation.
    Ye C; Zhang D; Zhao L; Li Y; Yao X; Wang H; Zhang S; Liu W; Cao H; Yu S; Wang Y; Jiang J; Wang H; Li X; Ying H
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genetic Variation on Human CaMKK2 Regulation by Ca
    O'Brien MT; Oakhill JS; Ling NX; Langendorf CG; Hoque A; Dite TA; Means AR; Kemp BE; Scott JW
    Sci Rep; 2017 Feb; 7():43264. PubMed ID: 28230171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors.
    Santiago ADS; Couñago RM; Ramos PZ; Godoi PHC; Massirer KB; Gileadi O; Elkins JM
    Sci Rep; 2018 Oct; 8(1):14800. PubMed ID: 30287839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
    York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
    Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.
    Subbannayya Y; Syed N; Barbhuiya MA; Raja R; Marimuthu A; Sahasrabuddhe N; Pinto SM; Manda SS; Renuse S; Manju HC; Zameer MA; Sharma J; Brait M; Srikumar K; Roa JC; Vijaya Kumar M; Kumar KV; Prasad TS; Ramaswamy G; Kumar RV; Pandey A; Gowda H; Chatterjee A
    Cancer Biol Ther; 2015; 16(2):336-45. PubMed ID: 25756516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
    Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
    Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder.
    Scott JW; Park E; Rodriguiz RM; Oakhill JS; Issa SM; O'Brien MT; Dite TA; Langendorf CG; Wetsel WC; Means AR; Kemp BE
    Sci Rep; 2015 Sep; 5():14436. PubMed ID: 26395653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation.
    Kola B; Korbonits M
    J Endocrinol; 2009 Aug; 202(2):191-8. PubMed ID: 19304759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The camKK2/camKIV relay is an essential regulator of hepatic cancer.
    Lin F; Marcelo KL; Rajapakshe K; Coarfa C; Dean A; Wilganowski N; Robinson H; Sevick E; Bissig KD; Goldie LC; Means AR; York B
    Hepatology; 2015 Aug; 62(2):505-20. PubMed ID: 25847065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems Metabolism.
    Marcelo KL; Ribar T; Means CR; Tsimelzon A; Stevens RD; Ilkayeva O; Bain JR; Hilsenbeck SG; Newgard CB; Means AR; York B
    Mol Endocrinol; 2016 May; 30(5):557-72. PubMed ID: 27003444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
    Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.